Association of Carotid Atherosclerosis Markers with All-cause and Cardiovascular Disease-specific Mortality in Persons with Type 2 Diabetes: a Causal Mediation Analysis with Glucose Variation

Overview

Journal Acta Diabetol

Specialty Endocrinology

Date 2024 Feb 23

PMID 38393346

Authors

Cheng-Chieh Lin

Chia-Ing Li

Chiu-Shong Liu

Chih-Hsueh Lin

Shing-Yu Yang

Tsai-Chung Li

Affiliations

Soon will be listed here.

Abstract

Aims: Glucose variation (GV) is independently associated with mortality in patients with diabetes. However, no study has examined the effects of carotid atherosclerosis markers on mortality after considering GV. Our purpose is to investigate the independent effects of carotid atherosclerosis markers in persons with type 2 diabetes (T2DM) after considering GV and the mediation effects of carotid atherosclerosis markers on associations between GV with cardiovascular disease (CVD) mortality.

Materials And Methods: This study is a retrospective cohort study including 3628 persons with T2DM who were admitted to a medical center between January 01, 2001 and October 31, 2021. GV was defined as a coefficient of variation (CV) of repeated measurements within a year before the index date (date of first IMT assessment). Carotid atherosclerosis markers included intima-media thickness (IMT), plaque, and stenosis. The outcomes consisted of all-cause and expanded cardiovascular disease (CVD) mortality. Cox proportional hazards models were applied.

Results: Among the participants, 286 (7.9%) had IMT ≥ 2 mm, 2834 (78.1%) had carotid plaque, and 464 (12.8%) had carotid stenosis ≥ 50%. When GV was considered, IMT, carotid plaque, and carotid stenosis were significant factors for all-cause mortality (except IMT considering HbA1c-CV) and expanded CVD mortality. IMT was a significant mediator in the associations of fasting plasma glucose (FPG)-CV with all-cause and expanded CVD mortality (2 and 3.19%, respectively), and carotid stenosis was a significant mediator in the association between FPG-CV and expanded CVD mortality (3.83%).

Conclusions: Our statistical evaluations show suggests that carotid atherosclerosis markers are important predictors of CVD mortality in persons with T2DM if GV is considered. In addition, IMT and carotid stenosis were significant mediators in the association between GV and mortality.

References

Chawla A, Chawla R, Jaggi S . Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?. Indian J Endocrinol Metab. 2016; 20(4):546-51. PMC: 4911847. DOI: 10.4103/2230-8210.183480. View

Booth G, Kapral M, Fung K, Tu J . Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006; 368(9529):29-36. DOI: 10.1016/S0140-6736(06)68967-8. View

Preis S, Pencina M, Hwang S, DAgostino Sr R, Savage P, Levy D . Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation. 2009; 120(3):212-20. PMC: 2789428. DOI: 10.1161/CIRCULATIONAHA.108.846519. View

Grundy S, Benjamin I, Burke G, Chait A, Eckel R, Howard B . Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999; 100(10):1134-46. DOI: 10.1161/01.cir.100.10.1134. View

Gu K, Cowie C, Harris M . Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998; 21(7):1138-45. DOI: 10.2337/diacare.21.7.1138. View

Wolf D, Ley K . Immunity and Inflammation in Atherosclerosis. Circ Res. 2019; 124(2):315-327. PMC: 6342482. DOI: 10.1161/CIRCRESAHA.118.313591. View

Nezu T, Hosomi N, Aoki S, Matsumoto M . Carotid Intima-Media Thickness for Atherosclerosis. J Atheroscler Thromb. 2015; 23(1):18-31. DOI: 10.5551/jat.31989. View

Darabian S, Hormuz M, Latif M, Pahlevan S, Budoff M . The role of carotid intimal thickness testing and risk prediction in the development of coronary atherosclerosis. Curr Atheroscler Rep. 2013; 15(3):306. PMC: 3583351. DOI: 10.1007/s11883-012-0306-4. View

OLeary D, Polak J . Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol. 2002; 90(10C):18L-21L. DOI: 10.1016/s0002-9149(02)02957-0. View

10.

van der Meer I, Bots M, Hofman A, Sol A, van der Kuip D, Witteman J . Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004; 109(9):1089-94. DOI: 10.1161/01.CIR.0000120708.59903.1B. View

11.

Nahmias A, Stahel P, Xiao C, Lewis G . Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor. Front Cardiovasc Med. 2020; 7:100. PMC: 7296136. DOI: 10.3389/fcvm.2020.00100. View

12.

Yang C, Lin C, Li C, Liu C, Lin C, Hwang K . Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes. Cardiovasc Diabetol. 2020; 19(1):4. PMC: 6945758. DOI: 10.1186/s12933-019-0978-y. View

13.

Mo Y, Zhou J, Ma X, Zhu W, Zhang L, Li J . Haemoglobin A1c variability as an independent correlate of atherosclerosis and cardiovascular disease in Chinese type 2 diabetes. Diab Vasc Dis Res. 2018; 15(5):402-408. DOI: 10.1177/1479164118778850. View

14.

Gorst C, Kwok C, Aslam S, Buchan I, Kontopantelis E, Myint P . Long-term Glycemic Variability and Risk of Adverse Outcomes: A Systematic Review and Meta-analysis. Diabetes Care. 2015; 38(12):2354-69. DOI: 10.2337/dc15-1188. View

15.

Zhao Q, Zhou F, Zhang Y, Zhou X, Ying C . Fasting plasma glucose variability levels and risk of adverse outcomes among patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract. 2018; 148:23-31. DOI: 10.1016/j.diabres.2018.12.010. View

16.

Ceriello A, Esposito K, Piconi L, Ihnat M, Thorpe J, Testa R . Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008; 57(5):1349-54. DOI: 10.2337/db08-0063. View

17.

Papachristoforou E, Lambadiari V, Maratou E, Makrilakis K . Association of Glycemic Indices (Hyperglycemia, Glucose Variability, and Hypoglycemia) with Oxidative Stress and Diabetic Complications. J Diabetes Res. 2020; 2020:7489795. PMC: 7585656. DOI: 10.1155/2020/7489795. View

18.

Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A . Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003; 52(11):2795-804. DOI: 10.2337/diabetes.52.11.2795. View

19.

Valente T, Arbex A . Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2020; 17(7):e071620183816. DOI: 10.2174/1573399816666200716201550. View

20.

Ghowsi M, Qalekhani F, Farzaei M, Mahmudii F, Yousofvand N, Joshi T . Inflammation, oxidative stress, insulin resistance, and hypertension as mediators for adverse effects of obesity on the brain: A review. Biomedicine (Taipei). 2022; 11(4):13-22. PMC: 8823488. DOI: 10.37796/2211-8039.1174. View